|
1
|
Jemal A, Siegel R, Xu J and Ward E: Cancer
statistics, 2010. CA Cancer J Clin. 60:277–300. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Memarzadeh S, Lee SB, Berek JS and
Farias-Eisner R: CA125 levels are a weak predictor of optimal
cytoreductive surgery in patients with advanced epithelial ovarian
cancer. Int J Gynecol Cancer. 13:120–124. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bast RC Jr, Xu FJ, Yu YH, Barnhill S,
Zhang Z and Mills GB: CA 125: The past and the future. Int J Biol
Markers. 13:179–187. 1998.
|
|
4
|
Bast RC Jr, Skates S, Lokshin A and Moore
RG: Differential diagnosis of a pelvic mass: Improved algorithms
and novel biomarkers. Int J Gynecol Cancer. 22(Suppl 1): S5–S8.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Salani R, Backes FJ, Fung MF, Holschneider
CH, Parker LP, Bristow RE and Goff BA: Posttreatment surveillance
and diagnosis of recurrence in women with gynecologic malignancies:
Society of Gynecologic Oncologists recommendations. Am J Obstet
Gynecol. 204:466–478. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Qian HN, Feng J, Cui H, Fu TY, Wei P and
Fu ZY: Generation and characterization of three monoclonal
antibodies to human ovarian epithelial adenocarcinomas. Chin Med J
(Engl). 102:839–843. 1989.
|
|
7
|
Qian HN: Immunohistological analysis of
monoclonal antibody COC166-9 against primary ovarian epithelial
cancer. Zhonghua Bing Li Xue Za Zhi. 17:207–209. 1988.(In Chinese).
PubMed/NCBI
|
|
8
|
Qian HN and Li WJ: Target therapy of
ovarian carcinoma by monoclonal antibodies bearing chemical drugs
entrapped in liposomes. Chin Med J (Engl). 106:343–347. 1993.
|
|
9
|
Li X, Qian H and Feng J: Preparation of
F(ab′)2 fragment of monoclonal antibody COC166-9 and its
experimental study of radioimmunoimaging for ovarian carcinoma.
Zhonghua Fu Chan Ke Za Zhi. 32:152–155. 1997.(In Chinese).
PubMed/NCBI
|
|
10
|
Chang X, Cui H, Feng J, Li Y, Liu B, Cao
S, Cheng Y and Qian H: Preparation of humanized ovarian carcinoma
anti-idiotypic minibody. Hybrid Hybridomics. 22:109–115. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Feng J, Lü J and Qian H: Serological
analysis of antibodies by anti-idiotypic monoclonal antibody 6B11
against ovarian carcinoma. Zhonghua Fu Chan Ke Za Zhi. 31:493–495.
1996.(In Chinese). PubMed/NCBI
|
|
12
|
Cui H, Chang XH, Liu B, Feng J, Li Y, Ye
X, Cao SJ, Fu TY, Yao Y, Li HQ, et al: The anti-tumor immune
responses induced by a fusion protein of ovarian carcinoma
anti-idiotypic antibody 6B11ScFv and murine GM-CSF in BALB/c mice.
Int J Gynecol Cancer. 14:234–241. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Shi J, Chang X, Feng J, Cheng Y, Cheng H,
Guo H, Ye X and Cui H: Expression of an ovarian cancer
anti-idiotype antibody (6B11VLVHCH3) in Chinese hamster ovary (CHO)
cells with improved immunoactivity and stability over proteins
expressed in prokaryotic cells. Hybridoma (Larchmt). 26:289–295.
2007. View Article : Google Scholar
|
|
14
|
Yang W, Feng J, Chang X, Fu T, Ye X, Zhang
H, Li X, Wen H, Feng L, Tong C, et al: Cytotoxic effects of T cells
induced by fusion protein 6B11-pulsed dendritic cells on ovarian
carcinoma cells. Gynecol Oncol. 105:238–243. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li W, Cui H, Meng FQ, Chang XH, Zhang G,
Liu B and Li ZH: New T cell epitopes identified from an
anti-idiotypic antibody mimicking ovarian cancer associated
antigen. Cancer Immunol Immunother. 57:143–154. 2008. View Article : Google Scholar
|
|
16
|
Stone GC, Sjöbring U, Björck L, Sjöquist
J, Barber CV and Nardella FA: The Fc binding site for streptococcal
protein G is in the C gamma 2-C gamma 3 interface region of IgG and
is related to the sites that bind staphylococcal protein A and
human rheumatoid factors. J Immunol. 143:565–570. 1989.PubMed/NCBI
|
|
17
|
Kimoto Y: Expression of heavy-chain
constant region of immunoglobulin and T-cell receptor gene
transcripts in human non-hematopoietic tumor cell lines. Genes
Chromosomes Cancer. 22:83–86. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Okabe H, Satoh S, Kato T, Kitahara O,
Yanagawa R, Yamaoka Y, Tsunoda T, Furukawa Y and Nakamura Y:
Genome-wide analysis of gene expression in human hepatocellular
carcinomas using cDNA microarray: Identification of genes involved
in viral carcinogenesis and tumor progression. Cancer Res.
61:2129–2137. 2001.PubMed/NCBI
|
|
19
|
Li J, Tan C, Xiang Q, Zhang X, Ma J, Wang
JR, Yang J, Li W, Shen SR, Liang S, et al: Proteomic detection of
changes in protein synthesis induced by NGX6 transfected in human
nasopharyngeal carcinoma cells. J Protein Chem. 20:265–271. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Qiu X, Zhu X, Zhang L, Mao Y, Zhang J, Hao
P, Li G, Lv P, Li Z, Sun X, et al: Human epithelial cancers secrete
immunoglobulin G with unidentified specificity to promote growth
and survival of tumor cells. Cancer Res. 63:6488–6495.
2003.PubMed/NCBI
|
|
21
|
Babbage G, Ottensmeier CH, Blaydes J,
Stevenson FK and Sahota SS: Immunoglobulin heavy chain locus events
and expression of activation-induced cytidine deaminase in
epithelial breast cancer cell lines. Cancer Res. 66:3996–4000.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ma C, Wang Y, Zhang G, Chen Z, Qiu Y, Li
J, Luo J, Huang B, Jiang C, Huang G, et al: Immunoglobulin G
expression and its potential role in primary and metastatic breast
cancers. Curr Mol Med. 13:429–437. 2013.PubMed/NCBI
|
|
23
|
Niu N, Zhang J, Huang T, Sun Y, Chen Z, Yi
W, Korteweg C, Wang J and Gu J: IgG expression in human colorectal
cancer and its relationship to cancer cell behaviors. PLoS One.
7:e473622012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Liu Y, Chen Z, Niu N, Chang Q, Deng R,
Korteweg C and Gu J: IgG gene expression and its possible
significance in prostate cancers. Prostate. 72:690–701. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chen Z, Huang X, Ye J, Pan P, Cao Q, Yang
B, Li Z, Su M, Huang C and Gu J: Immunoglobulin G is present in a
wide variety of soft tissue tumors and correlates well with
proliferation markers and tumor grades. Cancer. 116:1953–1963.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Li M, Zheng H, Duan Z, Liu H, Hu D, Bode
A, Dong Z and Cao Y: Promotion of cell proliferation and inhibition
of ADCC by cancerous immunoglobulin expressed in cancer cell lines.
Cell Mol Immunol. 9:54–61. 2012. View Article : Google Scholar
|
|
27
|
Manson LA: Anti-tumor immune responses of
the tumor-bearing host: The case for antibody-mediated immunologic
enhancement. Clin Immunol Immunopathol. 72:1–8. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hellström I, Hellström KE, Evans CA,
Heppner GH, Pierce GE and Yang JP: Serum-mediated protection of
neoplastic cells from inhibition by lymphocytes immune to their
tumor-specific antigens. Proc Natl Acad Sci USA. 62:362–368. 1969.
View Article : Google Scholar : PubMed/NCBI
|
